About Histoglob
Histoglob is a sterile preparation of Histamine dihydrochloride coupled to an active protein fraction extracted from human blood (Gamma-globulin) in strictly defined proportions. This conjugate is capable of eliciting an immunological response in the human body with the production of highly potent antihistaminic antibodies. Gamma-globulin used in testing. Histoglob is tested negative for HBsAg and Anti-HIV-1, 2 and Anti HCV Antibodies by ELISA and HBV, HIV & HCV by Nucleic acid is subjected to rigid stability test and electrophoretic analysis to ensure purity and safety.
Scientific Evidence
Articles
Infographics
.jpg)
Histoglob PFS offers a clinically considered immunotherapy option for chronic allergic rhinitis patients with inadequate control on conventional therapy or concerns about prolonged steroid use. Real-world experience highlights improved symptom-free intervals and reduced reliance on daily antihistamines and corticosteroids.
Conventional antihistamines may suppress symptoms temporarily, but recurrence is common after discontinuation. In real-world study, Histoglob PFS reduced steroid use by 67% and antihistamine dependency by 53%. Consider Histoglob PFS – Trusted adjuvant immunotherapy for long-term symptom control in your patients.
In a head-to-head clinical study, Histaglobulin provided superior symptom relief compared to nasal steroids; significantly reducing rhinorrhea, congestion, and sneezing. It also lowered eosinophil counts and serum IgE levels, targeting the immunologic root of allergic rhinitis. Consider Histoglob PFS – Trusted adjuvant immunotherapy for long-term symptom control in your patients.
20–30% of Indians battle allergic rhinitis, and around 35 million struggle with asthma. Conditions where standard treatments often fall short. Choose Histoglob for targeted, long-term immune support.
Up to 20% of individuals may experience urticaria in their lifetime, with chronic urticaria and atopic dermatitis affecting 0.5% to 5%. For long-term relief in these immune-driven conditions, consider Histoglob Adjuvant Immunotherapy.
Videos
With up to 30% of Indians suffering from allergies and over half seeking care for respiratory problems, the burden is undeniable. Histaglobulin empowers clinicians to break the allergy cycle and improve patient outcomes.
'My practise is a super speciality allergy one. Patients who come to me have tried every conceivable anti-allergy treatment under the sun before I see them. Histaglobulin allergy shots work in a different, more comprehensive way in eradication of all their allergies. Through a scientific well mediated mechanism, with absolutely zero side effects.'
'In my clinical practice, I frequently see patients where allergic rhinitis doesn't stop at the nose — it extends to the chest, presenting as asthma or allergic bronchitis. These overlapping conditions make management difficult, with patients often trapped in a cycle of recurring symptoms despite inhalers, antihistamines, and nasal sprays. One particular case involved a young adult with persistent nasal blockage, wheezing, and nighttime coughing that disrupted sleep and daily routine. Conventional therapy gave partial relief, but symptoms kept returning. That’s when I considered adding immunotherapy like Histaglobulin, which gradually helped reduce the frequency and severity of episodes. That dosage of drugs and the required duration of treatment also decreases with use of Histaglobulin on the other hand the symptoms free period increases( drug holiday).'
'Most allergy patients turn up to my Allergy Clinic after years of living with blocked noses difficulty in breathing disturbed sleep & dependency on Oral Antiallergics Inhalers & Nasal Sprays. They have tried all sorts of treatment in various pathies along with lifestyle modifications done to the maximum. Still the suffering remains because awareness regarding proper allergy management is lacking. Thus moving ahead of short-term pharmacotherapy treatment towards long term immunotherapy is important. Histaglobulin has been an integral part & corner stone of treatment given to patients who are ready to move beyond just short-lived symptomatic relief to long lasting asymptomatic life.'
Disclaimer:
The views and opinions expressed in this testimonial/video are of the healthcare providers and
are based on their experiences and do not necessarily reflect the views of BSV and/or its
officials. BSV hereby disclaims any and all liability arising directly or indirectly from any
use of the media content.
For adverse events please email us at pv@bsvgroup.com or connect with us via AER Form